Utah Medical Products, Inc.
UTMD
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $231.7M
$72.77
▲ +1.35%
P/E
22.20
Mkt Cap
$231.7M
52-Wk Range
$53.66–$75.75
52-Week Range
$53.66 - $75.75
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 18.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
6 reasons
- Specialized niche focus with limited direct competition in targeted medical specialties
- High-margin consumable products generating recurring revenue streams
- Strong brand recognition and customer loyalty in labor/delivery and women's health markets
- Lean manufacturing operations and efficient cost structure enabling profitability at smaller scale
- Proprietary product designs with established clinical adoption and switching costs
- Direct sales force relationships with hospitals, clinics, and physician offices
Bear Case
1 risk
- Low volatility (beta 0.4).
Growth
No forward estimates available
Expansion of women's health and gynecologic surgical product lines into new markets
Value
Valuation data unavailable
Momentum
Strong
+9.5% over 3m
Quality
Strong
Strong fundamentals
Dividend
Modest
1.70% yield
Smart-money signal
Who's buying UTMD right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 22, 2026
JUL 23, 2026
Most recent quarter reported revenue of $8.5M (-14% YoY). Reported EPS of $0.84. Gross margin 55.6%.
Reported EPS · last 4Q
0 of 1 beats
Q3 26
—
Revenue trend · last 8Q
—
-26%
-14%
-4%
-2%
-1%
-10%
-14%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$10.0M
$9.2M
$9.7M
$10.0M
$9.8M
$9.0M
$8.7M
$8.5M
Margins · last 8Q
Gross
55.6%
Operating
31.1%
Profit
31.5%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How UTMD stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related